1. Home
  2. NOTV vs NRT Comparison

NOTV vs NRT Comparison

Compare NOTV & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • NRT
  • Stock Information
  • Founded
  • NOTV 1974
  • NRT 1975
  • Country
  • NOTV United States
  • NRT United States
  • Employees
  • NOTV N/A
  • NRT N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • NRT Oil & Gas Production
  • Sector
  • NOTV Health Care
  • NRT Energy
  • Exchange
  • NOTV Nasdaq
  • NRT Nasdaq
  • Market Cap
  • NOTV 46.7M
  • NRT 50.9M
  • IPO Year
  • NOTV 1997
  • NRT N/A
  • Fundamental
  • Price
  • NOTV $1.43
  • NRT $5.34
  • Analyst Decision
  • NOTV Strong Buy
  • NRT
  • Analyst Count
  • NOTV 1
  • NRT 0
  • Target Price
  • NOTV $5.00
  • NRT N/A
  • AVG Volume (30 Days)
  • NOTV 342.4K
  • NRT 33.0K
  • Earning Date
  • NOTV 12-02-2025
  • NRT 08-29-2025
  • Dividend Yield
  • NOTV N/A
  • NRT 9.01%
  • EPS Growth
  • NOTV N/A
  • NRT 24.05
  • EPS
  • NOTV N/A
  • NRT 0.59
  • Revenue
  • NOTV $505,299,000.00
  • NRT $6,184,173.00
  • Revenue This Year
  • NOTV $5.64
  • NRT N/A
  • Revenue Next Year
  • NOTV $5.16
  • NRT N/A
  • P/E Ratio
  • NOTV N/A
  • NRT $9.15
  • Revenue Growth
  • NOTV 0.85
  • NRT 18.55
  • 52 Week Low
  • NOTV $1.15
  • NRT $3.88
  • 52 Week High
  • NOTV $6.48
  • NRT $5.87
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 44.87
  • NRT 48.33
  • Support Level
  • NOTV $1.25
  • NRT $5.31
  • Resistance Level
  • NOTV $1.55
  • NRT $5.66
  • Average True Range (ATR)
  • NOTV 0.12
  • NRT 0.20
  • MACD
  • NOTV 0.01
  • NRT -0.03
  • Stochastic Oscillator
  • NOTV 43.24
  • NRT 8.90

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: